WebFunding, Valuation & Revenue. Glooko's latest funding round was a Series D for $30M on March 16, 2024. Glooko's valuation in March 2015 was $78.87M. Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. WebNov 28, 2016 · Glooko mHealth Advantage Study The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not …
Glooko mHealth Advantage Study - Full Text View
WebDescription. Developer of a remote patient-monitoring platform intended to identify at-risk patients and provide quality-enhancing interventions. The company's platform synchronizes with diabetes devices, fitness wearables and activity trackers to enable data capture and provide reports and analytics that aim to drive behavior change and ... WebA funcionalidade Glooko Clinical Research permite que a sua clínica/hospital monitorize os participantes da investigação no seu Population Tracker. NOTA: De forma a manter as contas dos participantes da investigação separadas das contas de pacientes existentes, é atribuído à sua clínica um novo código ProConnect especificamente para a ... 固定資産税 1ldkマンション
Ed Nykaza - VP, Data Science & Clinical Research
WebNov 28, 2016 · Subject has a Glooko compatible smartphone/device with an active data plan or access to Wi-Fi and downloaded at least one mobile application on their phone on their own. Subject has performed self-monitoring of blood glucose at least five (5) times within two (2) weeks prior to screening visit. Exclusion Criteria: Subject has type 1 diabetes. WebAbout us. Glooko improves health outcomes of people with chronic conditions through its personalized, intelligent, connected care platform. Our proven technologies make lives better by ... WebMar 16, 2024 · Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, announced today a $30 million Series D funding round led by Health … 固定資産奉行i10 サポート終了